Health Media Articles

Excerpts of Key Health Media Articles in Major Media

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

The Food and Drug Administration [has admitted] that four New Jersey congressmen and its own former commissioner unduly influenced the process that led to its decision last year to approve a patch for injured knees. The agency’s scientific reviewers repeatedly and unanimously over many years decided that the device, known as Menaflex and manufactured by ReGen Biologics Inc., was unsafe because the device often failed, forcing patients to get another operation. But after receiving what an F.D.A. report described as “extreme,” “unusual” and persistent pressure from four Democrats from New Jersey ... agency managers overruled the scientists and approved the device for sale in December. All four legislators made their inquiries within a few months of receiving significant campaign contributions from ReGen, which is based in New Jersey, but all said they had acted appropriately and were not influenced by the money. Dr. Andrew C. von Eschenbach, the former drug agency’s commissioner, said he had acted properly. The agency has never before publicly questioned the process behind one of its approvals, never admitted that a regulatory decision was influenced by politics, and never accused a former commissioner of questionable conduct. The report, written by top agency officials, said that Dr. von Eschenbach, who resigned as F.D.A. commissioner in January, became as a result of political pressure “personally engaged in the details of a process usually coordinated” by scientific staff. One agency manager concluded that Dr. von Eschenbach “was demanding not only an expedited process but also an outcome in favor of ReGen,” the report stated.

Note: For a powerful summary of corruption in the pharmaceutical industry, click here.

Pharmaceutical companies will be able to produce about 3 billion doses of swine flu vaccine a year ... the World Health Organization said. The U.N. agency had previously predicted that companies would be able to make up to 5 billion doses each year. The World Health Organization admits that not everyone may need vaccination. "Most people will do well without the vaccine," WHO vaccine chief Marie-Paule Kieny told reporters. She said most people infected with the pandemic strain of the H1N1 virus have a mild illness and recover by themselves. Addressing concerns about the safety of the pandemic vaccine, WHO said trials to date suggest it is as safe as a regular seasonal flu shot. Kieny said large-scale vaccination programs would probably detect some cases of severe reaction following the vaccination, but that those would likely have occurred anyway without vaccination. The agency is urging countries to monitor the vaccination procedure for possible further side effects. Meanwhile WHO Director-General Dr. Margaret Chan repeated Thursday her recommendation that governments keep up their guard against swine flu but refrain from closing borders or restricting trade.

Note: With the cost of a regular flu vaccine dose ranging from about $20 to $30, do you think the pharmaceutical companies have any vested interest in the public being vaccinated? Let's see, 3 billion X $20 = $60 billion. Hmm. For more on the danger of this vaccine and rampant fear mongering, click here and here.

A federal judge has ruled that the government failed to adequately assess the environmental impacts of genetically engineered sugar beets before approving the crop for cultivation in the United States. The decision could lead to a ban on the planting of the beets, which have been widely adopted by farmers. Judge Jeffrey S. White of Federal District Court in San Francisco said that the Agriculture Department should have done an environmental impact statement. He said it should have assessed the consequences from the likely spread of the genetically engineered trait to other sugar beets. The decision echoes another ruling two years ago by a different judge in the same court involving genetically engineered alfalfa. In that case, the judge later ruled that farmers could no longer plant the genetically modified alfalfa until the Agriculture Department wrote the environmental impact statement. Two years later, there is still no such assessment. “We expect the same result here as we got in alfalfa,” said Andrew Kimbrell, executive director of the Center for Food Safety, a Washington advocacy group that was also involved in the alfalfa lawsuit. “It will halt almost any further planting and sale because it’s no longer an approved crop.” The Center for Food Safety was joined in the suit by the Sierra Club, the Organic Seed Alliance and High Mowing Organic Seeds, a small seed company. The beets contain a bacterial gene licensed by Monsanto that renders them impervious to glyphosate, an herbicide that Monsanto sells as Roundup. Judge White said that the pollen from the genetically engineered crops might spread to non-engineered beets.

Note: For an excellent overview of the dangers posed by genetically modified foods, click here. For other major media news articles revealing the dangers of already widespread GM foods, click here.

Shares of VeriChip Corp tripled after the company said it had been granted an exclusive license to two patents, which will help it to develop implantable virus detection systems in humans. The patents, held by VeriChip partner Receptors LLC, relate to biosensors that can detect the H1N1 and other viruses. The technology will combine with VeriChip's implantable radio frequency identification devices to develop virus triage detection systems. The triage system will provide multiple levels of identification -- the first will identify the agent as virus or non-virus, the second level will classify the virus and alert the user to the presence of pandemic threat viruses and the third level will identify the precise pathogen, VeriChip said in a white paper published May 7, 2009. Shares of VeriChip were up 186 percent.

Note: Beware of efforts to scare you into getting microchipped for your own safety. Click here for more on this. For more on pharmaceutical corporation profiteering from swine flu vaccines, click here.

The scientific integrity of medical research has been clouded in recent years by articles that were drafted by drug company-sponsored ghostwriters and then passed off as the work of independent academic authors. Yet the leading medical journals have continued to rely largely on an honor system of disclosure to detect such potential bias, asking authors to voluntarily report any industry ties or contributors to their manuscripts. But now, in light of recently released evidence that some drug makers have gone to great lengths to turn scientific articles into marketing vehicles for their products, some influential medical editors are cracking down on industry-financed ghostwriting. These editors are demanding that journals impose tougher disclosure policies for academic authors and that the journals enforce their own rules by actively investigating the provenance of manuscripts and by punishing authors who play down extensive contributions by ghostwriters. Calling for a zero tolerance policy, the editors of the medical journal PLoS Medicine, from the Public Library of Science, called for journals to identify and retract ghostwritten articles and banish their authors. “Authors found to have not declared such interest should be banned from any subsequent publication in the journal and their misconduct reported to their institutions.” In the past, researchers have raised allegations of ghostwriting in articles about quality-of-life drugs like antidepressants, painkillers and diet pills. But the situation has become more serious this year after a few editors said they had discovered ghostwriting in manuscripts about life-and-death products like cancer and hematology drugs.”

Note: For background on the prevalence of ghostwriting in major medical journals, click here and here and here.

A freelance cameraman's appendix ruptured and by the time he was admitted to surgery, it was too late. A self-employed mother of two is found dead in bed from undiagnosed heart disease. A 26-year-old aspiring fashion designer collapsed in her bathroom after feeling unusually fatigued for days. What all three of these people have in common is that they experienced symptoms, but didn't seek care because they were uninsured and they worried about the hospital expense, according to their families. All three died. Research released ... in the American Journal of Public Health estimates that 45,000 deaths per year in the United States are associated with the lack of health insurance. If a person is uninsured, "it means you're at mortal risk," said one of the authors, Dr. David Himmelstein, an associate professor of medicine at Harvard Medical School. The researchers examined government health surveys from more than 9,000 people aged 17 to 64, taken from 1986-1994, and then followed up through 2000. They determined that the uninsured have a 40 percent higher risk of death than those with private health insurance as a result of being unable to obtain necessary medical care. The researchers then extrapolated the results to census data from 2005 and calculated there were 44,789 deaths associated with lack of health insurance.

Note: For key reports on important health issues from reliable sources, click here.

A shipwreck apparently containing toxic waste is being investigated by authorities in Italy amid claims that it was deliberately sunk by the mafia. An informant from the Calabrian mafia said the ship was one of a number he blew up as part of an illegal operation to bypass laws on toxic waste disposal. The sunken vessel has been found 30km (18 miles) off the south-west of Italy. The informant said it contained "nuclear" material. Officials said it would be tested for radioactivity. Murky pictures taken by a robot camera show the vessel intact and alongside it are a number of yellow barrels. Labels on them say the contents are toxic. The informant said the mafia had muscled in on the lucrative business of radioactive waste disposal. But he said that instead of getting rid of the material safely, he blew up the vessel out at sea, off the Calabrian coast. He also says he was responsible for sinking two other ships containing toxic waste. For years there have been rumours that the mafia was sinking ships with nuclear and other waste on board, as part of a money-making racket. The environmental campaign group Greenpeace and others have compiled lists over the past few decades of ships that have disappeared off the coast of Italy and Greece. Processing waste is highly specialised and is supposed to be an industry where security is the top priority. If tests show that there is nuclear material on the seabed it will prove that the mafia has moved into its dirtiest business yet.

The nation's political crosscurrents appear to have created vaccine skeptics of many stripes. Many citizens are less inclined than ever to accept the warnings of the Department of Health and Human Services or the recommendations of its Centers for Disease Control and Prevention, says Sandra Quinn, a University of Pittsburgh public health professor who has just completed a national survey of attitudes about the flu vaccine. Vaccine refusers have long decried vaccine mandates and campaigns as an unwarranted intrusion of parents' and local school boards' rights. For a new generation of vaccine skeptics, there are new objects of distrust. For some, it flows from a suspicion of the multinational corporations that develop and manufacture vaccines. For others, it comes from a belief that media outlets have hyped the pandemic flu story to secure the attention of readers and the revenue of advertisers. And many simply doubt the competency and independence of government agencies, which they believe are too inept, overwhelmed or co-opted by corporate interests to secure the safety of the nation's drugs and food supply. Adding to the wariness toward the forthcoming H1N1 vaccine is the fact that the formulations used on patients in the United States might require the use of adjuvants -- special agents added to a vaccine mix that rev up the immune system and foster a stronger immune response. While adjuvants have been used in vaccines in Europe for many years, the FDA has never approved them for widespread use in the United States. Some vaccine critics in Great Britain have charged that one adjuvant used in European formulations -- squalene -- is associated with a wide range of vague but persistent symptoms.

Note: Adjuvants are being added to vaccines, yet the resulting combined formula is not being tested for safety; the individual components are tested separately. The process for the testing of vaccines is endangering our health. For lots more on the dangers of vaccines and squalene in particular, read respected Dr. Joseph Mercola's incisive article available here.

To listen to President Obama, or to just about anyone else in the health care debate, you would think that the biggest problem with health care in America is the system itself — perverse incentives, inefficiencies, unnecessary tests and procedures, lack of competition, and greed. No one disputes that the $2.3 trillion we devote to the health care industry is often spent unwisely, but the fact that the United States spends twice as much per person as most European countries on health care can be substantially explained, as a study released last month says, by our being fatter. Even the most efficient health care system that the administration could hope to devise would still confront a rising tide of chronic disease linked to diet. That’s why our success in bringing health care costs under control ultimately depends on whether Washington can summon the political will to take on and reform a second, even more powerful industry: the food industry. According to the Centers for Disease Control and Prevention, three-quarters of health care spending now goes to treat “preventable chronic diseases.” Not all of these diseases are linked to diet — there’s smoking, for instance — but many, if not most, of them are. We’re spending $147 billion to treat obesity, $116 billion to treat diabetes, and hundreds of billions more to treat cardiovascular disease and the many types of cancer that have been linked to the so-called Western diet. One recent study estimated that 30 percent of the increase in health care spending over the past 20 years could be attributed to the soaring rate of obesity, a condition that now accounts for nearly a tenth of all spending on health care. The American way of eating has become the elephant in the room in the debate over health care.

Note: For a detailed overview of some of the critical risks of the industrially-engineered modern American diet, click here.

A new food-labeling campaign called Smart Choices, backed by most of the nation’s largest food manufacturers, is “designed to help shoppers easily identify smarter food and beverage choices.” The green checkmark label that is starting to show up on store shelves will appear on hundreds of packages, including — to the surprise of many nutritionists — sugar-laden cereals like Cocoa Krispies and Froot Loops. “These are horrible choices,” said Walter C. Willett, chairman of the nutrition department of the Harvard School of Public Health. He said the criteria used by the Smart Choices Program were seriously flawed, allowing less healthy products, like sweet cereals and heavily salted packaged meals, to win its seal of approval. “It’s a blatant failure of this system and it makes it, I’m afraid, not credible,” Mr. Willett said. Froot Loops qualifies for the label because it meets standards set by the Smart Choices Program for fiber and Vitamins A and C, and because it does not exceed limits on fat, sodium and sugar. It contains the maximum amount of sugar allowed under the program for cereals, 12 grams per serving, which in the case of Froot Loops is 41 percent of the product. That is more sugar than in many popular brands of cookies. “Froot Loops is an excellent source of many essential vitamins and minerals and it is also a good source of fiber with only 12 grams of sugar,” said Celeste A. Clark, senior vice president of global nutrition for Kellogg’s, which makes Froot Loops. Dr. Clark, who is a member of the Smart Choices board, said that the program’s standard for sugar in cereals was consistent with federal dietary guidelines.

Note: For many revealing reports on health issues, click here.

The pharmaceutical giant Pfizer agreed to pay $2.3 billion to settle civil and criminal allegations that it had illegally marketed its painkiller Bextra, which has been withdrawn. It was the largest health care fraud settlement and the largest criminal fine of any kind ever. The settlement had been expected. Pfizer, which is acquiring a rival, Wyeth, reported in January that it had taken a $2.3 billion charge to resolve claims involving Bextra and other drugs. It was Pfizer’s fourth settlement over illegal marketing activities since 2002. The government charged that executives and sales representatives throughout Pfizer’s ranks planned and executed schemes to illegally market not only Bextra but also Geodon, an antipsychotic; Zyvox, an antibiotic; and Lyrica, which treats nerve pain. While the government said the fine was a record sum, the $2.3 billion fine amounts to less than three weeks of Pfizer’s sales. Much of the activities cited Wednesday occurred while Pfizer was in the midst of resolving allegations that it illegally marketed Neurontin, an epilepsy drug for which the company in 2004 paid a $430 million fine and signed a corporate integrity agreement — a companywide promise to behave. John Kopchinski, a former Pfizer sales representative whose complaint helped prompt the government’s Bextra case, said that company managers told him and others to dismiss concerns about the Neurontin case while pushing them to undertake similar illegal efforts on behalf of Bextra. “The whole culture of Pfizer is driven by sales, and if you didn’t sell drugs illegally, you were not seen as a team player,” said Mr. Kopchinski.

Note: For lots more on corporate corruption, click here. For a powerful article on the immense political power of pharmaceutical companies by one of the top MDs in the U.S., click here.

The electromagnetic waves emitted by mobile phone towers and cellphones can pose a threat to honey bees, a study published in India has concluded. An experiment conducted in the southern state of Kerala found that a sudden fall in the bee population was caused by towers installed across the state by cellphone companies to increase their network. The electromagnetic waves emitted by the towers crippled the "navigational skills" of the worker bees that go out to collect nectar from flowers to sustain bee colonies, said Dr. Sainuddin Pattazhy, who conducted the study. He found that when a cell phone was kept near a beehive, the worker bees were unable to return, leaving the hives with only the queens and eggs and resulting in the collapse of the colony within ten days. Over 100,000 people in Kerala are engaged in apiculture and the dwindling worker bee population poses a threat to their livelihood. The bees also play a vital role in pollinating flowers to sustain vegetation. If towers and mobile phones further increase, honey bees might be wiped out in 10 years, Pattazhy said.

To the credit of opponents of health-care reform, the lies and exaggerations they're spreading are not made up out of whole cloth—which makes the misinformation that much more credible. Instead, because opponents demand that everyone within earshot (or e-mail range) look, say, "at page 425 of the House bill!," the lies take on a patina of credibility. Take the claim in one chain e-mail that the government will have electronic access to everyone's bank account, implying that the Feds will rob you blind. The 1,017-page bill passed by the House Ways and Means Committee does call for electronic fund transfers—but from insurers to doctors and other providers. There is zero provision to include patients in any such system. Five other myths that won't die: [1] You'll have no choice in what health benefits you receive. [2] No chemo for older Medicare patients. A related myth is that health-care reform will be financed through $500 billion in Medicare cuts. This refers to proposed decreases in Medicare increases. [3] Illegal immigrants will get free health insurance. [4] Death panels will decide who lives. [5] The government will set doctors' wages. To be sure, there are also honest and principled objections to health-care reform. Some oppose a requirement that everyone have health insurance as an erosion of individual liberty. And many are simply scared out of their wits about what health-care reform will mean for them. But when fear and loathing hijack the brain, anything becomes believable.

Note: For lots more on health issues from major media sources, click here.

Chevron Corp., California's largest company and one of the world's largest oil producers, will soon face a day of reckoning. After 16 years of litigation, a case the company inherited in a merger, Aguinda vs. Texaco Inc., is nearing an end. The legal battle that began in the United States in 1993 and resumed in Ecuador in 2003 has pitted the multinational against an unlikely adversary, a coalition of indigenous tribes and communities. A verdict is expected early next year. The plaintiffs are poised to prevail, and Chevron acknowledges that it is likely to lose. The case is historic by several measures. Never before have indigenous peoples brought a multinational oil corporation to trial in their own country. Moreover, a victory would mark a turning point in the relations between native populations around the world and the foreign corporations that do business in their homelands. And the potential damages are staggering: A court-appointed expert has determined that they could run to $27 billion, almost 10 times that initially awarded to plaintiffs after the Exxon Valdez oil spill. Today, a swath of the Ecuadorean Amazon the size of Rhode Island remains contaminated beyond imagining. At one site after another, oil hangs in the air, slides on the water's surface and saturates the land. Pipelines and waste pits left behind years ago still drip and ooze. Advocates for the plaintiffs have called the former Texaco concession area the "Amazon Chernobyl." Were it in the United States, it would easily qualify as a Superfund site. Neither side in the case disputes the devastation, only who should pay for it.

Note: For the inspiring story of the courageous Ecuadorian lawyer behind this David vs. Goliath lawsuit, click here. A smear campaign by Chevron against the judge in this case has more recently swayed opinion in favor of Chevron again. Contact your political and media representatives at this link to express your opinion.

Billionaire Mayor Michael Bloomberg defended multibillion-dollar pharmaceutical companies and their chief executives on Friday, declaring that they "don't make a lot of money" and shouldn't be scapegoats in the health care debate. The mayor — and wealthiest person in New York City with a fortune estimated at $16.5 billion — made the comments on his radio show Friday. "You know, last time I checked, pharmaceutical companies don't make a lot of money, their executives don't make a lot of money," Bloomberg said. Pharmaceutical CEOs are known to make millions, with generous salaries, stock options and other perks. Abbott Laboratories Inc. Chairman and Chief Executive Miles White's compensation was $25.3 million in 2008. The North Chicago, Ill.-based company saw profit rising 35 percent to $4.88 billion. Merck & Co.'s chief executive, Richard T. Clark, received a $17.3 million compensation package for 2008. The company's profit more than doubled to $7.8 billion. The mayor ... often battles criticism that he is out of touch with regular people. Earlier this year he declared "we love the rich people" while arguing against raising taxes on the wealthy. It was clear that Bloomberg or one of his aides realized his gaffe while he was still on the air Friday. The mayor, who has sought to cast himself as a financial and business expert, came back from a break and said he had looked up the pay of some pharmaceutical executives. "Some of them are making a decent amount, more than a decent amount of money," he said.

In a study, researchers have found that long-term pot smokers were roughly 62 percent less likely to develop head and neck cancers than people who did not smoke pot. The new study featured 434 patients with head and neck cancers, which include tumors in the mouth, tongue, nose, sinuses, throat and lymph nodes in the neck, and 547 individuals without these cancers seen in the Greater Boston area from December 1999 to December 2003. After factoring out the impact of smoking, drinking, and other factors that might influence the results, smoking marijuana from once every two weeks to three times every two weeks, on average, was associated with about half the risk of head and neck cancer, compared with less frequent use. Those who took up pot smoking at an older age appeared to have less risk of these cancers than those who started it at a younger age. Compared to people who never smoked pot, those who began smoking marijuana between the ages of 15 and 19 years were 47 percent less likely to develop head and neck cancer, while users who began at age 20 or older had a 61 percent reduced risk, Kelsey and colleagues found. The authors note that chemicals in pot called cannabinoids have been shown to have potential antitumor effects. Other studies have linked marijuana use to a reduced risk of some cancers, such as cancer of the prostate, and now head and neck cancer. It's also been suggested that smoking pot may help stave off Alzheimer's disease and help combat weight loss associated with AIDS, and nausea and vomiting associated with chemotherapy in cancer patients.

Note: For a great nine-minute video presenting major media reports showing how marijuana is a very promising cancer treatment that is being suppressed, click here. For deeply revealing reports from reliable major media sources on health issues, click here.

U.S. government health officials are urging Americans not to panic over estimates that up to 90,000 people might die in the United States from swine flu this year. "Everything we've seen in the U.S. and everything we've seen around the world suggests we won't see that kind of number if the virus doesn't change," said Dr. Thomas Frieden, head of the Centers for Disease Control and Prevention. While the swine flu seems quite easy to catch, it so far hasn't been more deadly than the flu strains seen every fall and winter — many people have only mild illness. And close genetic tracking of the new virus as it circled the globe over the last five months so far has shown no sign that it's mutating to become more virulent. Still, the CDC has been preparing for a worst-case flu season as a precaution — in July working from an estimate slightly more grim than one that made headlines this week — to make sure that if the virus suddenly worsened or vaccination plans fell through, health authorities would know how to react. On Monday the White House released a report from a group of presidential advisers that included a scenario where anywhere from 30 percent to half of the population could catch what doctors call the "2009 H1N1" flu, and death possibilities ranged from 30,000 to 90,000. "We don't think that's the most likely scenario," CDC flu specialist Dr. Anne Schuchat said of the presidential advisers' high-end tally. In a regular flu season, up to 20 per cent of the population is infected and 36,000 die.

Note: Like the avian flu several years ago, the swine flu is turning out to be largely fear-mongering which has poured billions of dollars into the deep pockets of the medical/industrial complex. For lots more reliable information from major media reports on this, click here.

Many GPs, as well as their patients, may be reluctant to be immunised against swine flu once a vaccine is developed, surveys suggest today. A survey of GPs published on Healthcare Republic, the website of GP magazine, found that up to 60% of GPs may decline vaccination. Although the numbers who responded were small – 216 GPs – they are in line with a much bigger survey of nurses published a week ago by Nursing Times, which found that a third of 1,500 nurses would refuse vaccination. A Canadian study published today in the journal Emerging Health Threats suggests the public, too, will have reservations that must be overcome if a vaccination campaign is to be successful in the autumn or winter. The study, which used focus groups to establish the likely response of different people to a vaccine, pointed to the need to win over people who believe that alternative therapies and a good diet are a better option than vaccines. But the biggest problem in persuading people and healthcare professionals to have the jab may be the relative shortage of evidence from trials about its safety and efficacy. Because of the urgent need for a vaccine, testing will be limited. Among the GPs who responded to the survey published by Healthcare Republic, 29% said they would not choose to have the vaccine and 29% said they were unsure whether or not they would. The biggest reason given by those who said they would not have it was concern that the safety trials would not be adequate: 71.3% said they were "concerned that the vaccine has not yet been through sufficient trials to guarantee safety". Half – 50.4% – said they "believe that swine flu is too mild to justify taking the vaccine".

Note: Yet the Massachusetts Senate has now passed a bill which would impose fines up to $1,000 and jail up to 30 days for those who refuse vaccines or quarantine orders in a health emergency. Other states are considering similar legislation. For lots more on the real dangers of the swine flu vaccine, click here.

Healthy people who catch swine flu but show only mild symptoms should not be given Tamiflu, the World Health Organisation (WHO) has said. The advice contradicts British policy on the issue, which has seen hundreds of thousands of doses of the antiviral given to people with the virus. Today's advice, published on the WHO website, said most patients were experiencing typical flu symptoms and would get better within a week. It said Tamiflu (also called oseltamivir) and another antiviral Relenza (also called zanamivir) should not be given to healthy people who have only mild symptoms. The latest WHO advice, from a panel of international experts, comes as new figures show that 45,986 courses of antivirals were given to patients in England in the week ending August 18. In the previous week, 90,363 courses of antivirals were given out. There have been fears that mass use of Tamiflu will encourage the virus to become resistant to the antiviral. Researchers have also expressed concern over the side effects of the drug, including sickness, nightmares and insomnia in children. A team from Oxford University said earlier this month children with mild symptoms should not be given the antiviral to combat swine flu and urged the Department of Health to urgently rethink its policy.

Note: To read an article showing Tamiflu and Relenza may not be safe for children, click here. For other incisive articles revealing major manipulations involving the swine flu, click here.

The flu drugs Tamiflu and Relenza may not be worthwhile to treat seasonal influenza in healthy adults, British researchers reported on Friday. "Recommending the use of antiviral drugs for the treatment of people presenting with symptoms is unlikely to be the most appropriate course of action," wrote Jane Burch of the University of York and colleagues. Their study, published in the Lancet Infectious Diseases, supports an advisory from the World Health Organization that says healthy patients who get H1N1 swine flu without suffering complications do not need to be treated with antivirals. Burch's team reviewed many different published studies on Tamiflu and Relenza. "We present the results for healthy adults and people at-risk of influenza-related complications," they wrote. Both drugs shaved about half a day, on average, off the time patients were ill, they found. Influenza usually affects people for about a week. The drugs worked a little better in people who have a high risk of complications, such as patients with diabetes or asthma, with Relenza cutting sickness by almost a day and Tamiflu by three-quarters of a day, on average. This suggests the drugs should be reserved for people who need them the most, the researchers concluded.

Note: To read a powerful account of the real dangers of the swine flu scare, click here.

Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.